甘李药业股份有限公司2025年度权益分派实施公告深度解读
主要内容及关键点
- 每股现金分红比例：每股派发现金红利1元（含税），总计派发约5.97亿元。
- 相关重要日期：
- 股权登记日：2026年5月28日
- 除权（息）日及现金红利发放日：2026年5月29日
- 分红对象：截至股权登记日收市后在中国结算上海分公司登记在册的全体股东。
- 分红方案：以公司总股本597,304,969股为基数，派发现金红利共计597,304,969元。
- 差异化分红送转：否。
详细分配实施办法
- 派发方式：
- 无限售条件流通股红利通过中国结算上海分公司资金清算系统向办理了指定交易的股东派发。
- 未办理指定交易股东红利暂由中国结算上海分公司保管，待办理后再派发。
- 公司股东甘忠如先生和北京旭特宏达科技有限公司红利由公司自行发放。
- 税务处理说明：
- 自然人股东及证券投资基金：根据持股期限不同，股息红利税负及征收方式不同。公司暂不扣税，实际派发现金红利为1元/股，税务由股份托管机构在转让股票时扣收。
- 合格境外机构投资者（QFII）：公司按10%税率代扣代缴企业所得税，税后每股派发0.9元。如需享受税收协定待遇可自行申请。
- 沪港通投资者：同样按10%税率代扣代缴，税后派发0.9元/股，可申请退税。
- 其他法人及机构投资者：自行缴纳所得税，实际派发为税前每股1元。
可能影响股价的重要信息
- 大额现金分红：此次分红方案显示公司盈利能力充足，且现金流稳健。每股现金分红1元属于较高水平，对于投资者来说是实质性的利好。
- 分红政策稳定：公司未实施差异化分红送转，显示分红政策的稳定性，可能提升市场信心。
- 税务政策影响：分红税务政策细化，尤其对于不同类型投资者（自然人、QFII、沪港通、机构）影响实际到手红利金额，投资者需关注自身税务情况。
- 价格调整：公告特别指出权益分派后，股权激励相关价格将做相应调整，具体价格调整方案待后续公告，这部分可能影响公司股价及相关激励对象利益。
- 分红实施时间明确：除权日期、发放日期明确，分红落地预期强，有助于提升公司股价短期表现。
- 公司治理透明：公告由董事会及全体董事保证真实、准确、完整，显示公司治理透明与规范。
投资者特别关注事项
- 分红领取方式及税务处理需投资者根据自身身份（自然人、机构、境外投资者等）提前准备。
- 未办理指定交易的股东需尽快办理，否则红利将暂由中国结算上海分公司保管。
- 如需享受税收优惠或协定待遇，境外投资者需自行向税务机关申请。
- 股权激励价格调整可能影响相关利益，需关注后续公告。
联系方式
如有相关疑问，可联系公司证券部，电话：010-80593699。
免责声明
本文仅为公告信息整理及解读，不构成投资建议。投资者应自行评估相关风险及税务影响，具体分红政策以公司公告及相关监管政策为准。股价波动受多种因素影响，本文不对价格走势作任何保证。
English Version:
Gan & Lee Pharmaceuticals Co., Ltd. 2025 Annual Dividend Distribution Announcement – In-depth Analysis
Main Points & Highlights
- Cash Dividend per Share: RMB 1 per share (before tax), totaling approximately RMB 597 million.
- Key Dates:
- Shareholder record date: May 28, 2026
- Ex-right (ex-dividend) & dividend payment date: May 29, 2026
- Eligible Shareholders: All shareholders registered with China Securities Depository and Clearing Shanghai Branch at market close on the record date.
- Distribution Plan: Based on total share capital of 597,304,969 shares, total cash dividend to be distributed is RMB 597,304,969.
- No differentiated bonus issue: Confirmed.
Detailed Implementation Methods
- Distribution Method:
- Cash dividends for unrestricted circulating shares will be paid via the clearing system to shareholders who have processed designated trading.
- Dividends for shareholders who have not processed designated trading will be kept by the clearing company until they do so.
- Dividends for shareholders Gan Zhongru and Beijing Xu Te Hong Da Technology Co., Ltd. will be paid directly by the company.
- Tax Treatment:
- Individual shareholders & securities investment funds: Different tax policies depending on holding period. The company does not withhold tax at distribution; actual dividend is RMB 1/share, tax will be withheld at time of share transfer.
- Qualified Foreign Institutional Investors (QFII): 10% enterprise income tax withheld, after-tax dividend is RMB 0.90/share. May apply for treaty benefits if eligible.
- Hong Kong Stock Connect Investors: 10% tax withheld, after-tax dividend RMB 0.90/share. Can apply for tax refund if entitled to treaty benefits.
- Other corporate and institutional investors: Responsible for their own income tax, pre-tax dividend RMB 1/share.
Potential Price-Sensitive Information
- High Cash Dividend: Indicates strong profitability and cash flow. RMB 1/share cash dividend is substantial and a positive signal for investors.
- Stable Dividend Policy: No differentiated dividend, reflects policy stability and may boost market confidence.
- Tax Policy Impact: Detailed tax arrangements for different investor categories affect actual dividend received. Investors need to be aware of their own tax status.
- Price Adjustment: Announcement notes that post-dividend, equity incentive-related prices will be adjusted; details to follow in subsequent announcements. This could affect share price and incentive recipients.
- Clear Timeline: Precise ex-right and payment dates reinforce the dividend payout expectation, potentially boosting short-term share performance.
- Transparent Governance: Board guarantees authenticity and completeness; reflects strong corporate governance.
Investor Attention Points
- Dividend collection and tax treatment depends on investor category; prepare accordingly.
- Shareholders who have not processed designated trading should do so promptly; otherwise, dividends will be held by the clearing company.
- Foreign investors requiring tax treaty benefits must apply to relevant tax authorities.
- Equity incentive price adjustments may affect relevant interests; monitor subsequent announcements.
Contact Information
For queries regarding this dividend, contact the Securities Department at 010-80593699.
Disclaimer
This article is for information collation and interpretation only and does not constitute investment advice. Investors should independently assess risks and tax implications. Specific dividend policies are subject to company announcements and regulatory policies. Share price movement is affected by multiple factors; no guarantee of price direction is provided herein.
